DUBLIN–(BUSINESS WIRE)–The “Stromal Vascular Fraction – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Global Stromal Vascular Fraction Market to Reach $101 Million by 2027
Amid the COVID-19 crisis, the global market for Stromal Vascular Fraction estimated at US$75.7 Million in the year 2020, is projected to reach a revised size of US$101 Million by 2027, growing at a CAGR of 4.2% over the period 2020-2027.
Isolation Products, one of the segments analyzed in the report, is projected to record a 4% CAGR and reach US$79.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Aspiration Products segment is readjusted to a revised 4.9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $27.2 Million, While China is Forecast to Grow at 5.5% CAGR
The Stromal Vascular Fraction market in the U.S. is estimated at US$27.2 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$8.1 Million by the year 2027 trailing a CAGR of 5.5% over the period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.4% and 3.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.
Transfer Products Segment to Record 4.5% CAGR
In the global Transfer Products segment, USA, Canada, Japan, China and Europe will drive the 4.5% CAGR estimated for this segment.
These regional markets accounting for a combined market size of US$2.3 Million in the year 2020 will reach a projected size of US$3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.
What’s New for 2022?
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies – Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to a digital archives and Research Platform
- Complimentary updates for one year
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Stem Cells, Application Areas, and the Different Types: A Prelude
- Applications of Stem Cells
- Types of Stem Cells
- Stromal Vascular Fraction: An Introduction
- Production Method for SVF
- SVF Cell Procedure
- SVF Composition, Content, and Source
- SVF: Mechanism of Action
- SVF: Clinical Applications
- Safety and Efficiency of SVF
- Clinical Trials and Regulations Related to SVF
- Limitations and Scope
- Impact of Covid-19 and a Looming Global Recession
- COVID-19 Impact on Stromal Vascular Fraction Market
- Extensive Therapeutic Scope Set to Stimulate Growth of Global Stromal Vascular Fraction Market
- Soft Tissue Segment Leads the Market
- North America Dominates the Global Market, Asia-Pacific to Witness Fastest Growth
- Lucrative Opportunities & Restraints
- Market Restraints
- Salient Drivers Offering Growth Impetus to Stromal Vascular Fraction Market
- Extensive Application Scope
- Rising Focus on Non-Enzymatic Isolation Techniques
- Strong Research Focus on Optimization of Tissue Recovery
- Consistent Efforts to Develop Better Cell Therapies
- Competition
- Players Bet on Product Innovation to Push Footprint in Stromal Vascular Fraction Market
- Recent Market Activity
- SVF Isolation Products Continue to Make Gains
2. FOCUS ON SELECT PLAYERS (Total 25 Featured)
- Cellular Biomedicines Group, Inc.
- Cytori Therapeutics, Inc.
- GE Healthcare
- Genesis Biosystems, Inc.
- Human Med AG
- InGeneron, Inc.
- KYOCERA Corporation
- Tissue Genesis Inc.
3. MARKET TRENDS & DRIVERS
- Regenerative Medicine: A Promising Application of Stromal Vascular Fraction
- Increased Prevalence of Musculoskeletal Disorders & Knee Osteoarthritis Steers Market Expansion
- Use of SVF in Osteoarthritis Treatment
- Surging Demand for Aesthetic & Reconstructive Therapies Enhances Market Prospects
- Increasing Awareness about Stem Cell Therapy Augurs Well
- Innovative Methods Become Relevant in Optimizing Tissue Recovery
- Stromal Vascular Formation Holds Significance for Chronic Diseases
- Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
- Stromal Vascular Fraction in Diabetic Care
- Low Temperature Settings Optimize Vitality of Adipose Tissue-derived SVFs
- SVF Offers Helpful Microenvironment to Regulate ASC Activity under Specific Clinical Conditions
- Swift Influx of Stem Cell Therapies Requires Alternate Regulatory Pathway Covering Autologous SVF
- The Counterview
- Contrast with Regulatory Framework Covering HCT/Ps
- Aging Demographics Add to the Global Burden of Chronic Diseases, Presenting Opportunities for Stromal Vascular Fracture
- High Incidence of Neurological Disorders: A Key Market Driver
- Annual Incidence of Adult-Onset Neurologic Disorders in the US
- Diagnosed Prevalence Cases of Parkinson’s Disease Across Select Countries
- Increase in Healthcare Spending Stirs Demand for Stromal Vascular Formation
- Expansion of Private Hospitals in Rural Areas
4. GLOBAL MARKET PERSPECTIVE
III. REGIONAL MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/sy807h
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
